October 28, 2016 5:53 AM ET


Company Overview of Intarcia Therapeutics, Inc.

Key Executives for Intarcia Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Kurt C. Graves 59 RelationshipsExecutive Chairman, Chief Executive Officer and President48
James M. Ahlers No RelationshipsChief Financial Officer and Vice President of Finance & Operations52
Michael Williams No RelationshipsChief Operating Officer--
Michelle Baron M.D., FACENo RelationshipsChief Medical Officer and Vice President of Clinical Research--
Paul L. Feldman Ph.D.No RelationshipsHead of Discovery & Translational Medicine--
View More Key Executives

Intarcia Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Kurt C. Graves 59 RelationshipsIntarcia Therapeutics, Inc.48
Bryan E. Roberts Ph.D. 149 RelationshipsCastlight Health, Inc.49
Glen Y. Sato J.D., M.B.A. 40 RelationshipsCooley LLP57
Irwin Scher M.D. 7 RelationshipsBiosynexus Incorporated66
Gino Santini 75 RelationshipsAMAG Pharmaceuticals, Inc.59
View All Board Members

Intarcia Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Intarcia Therapeutics, Inc. CEO Compensation
Industry Average


ERYTECH Pharma Appoints Management Team
October 27, 2016 5:45 AM ET
Cerulean Pharma Inc Promotes Scott Eliasof, Phd to the Role of Senior Vice President and Chief Scientific Officer
October 26, 2016 5:22 PM ET
BriaCell Therapeutics Corp. Appoints William Williams as President, CEO and Member of its Board of Directors, Effective November 1, 2016
October 26, 2016 3:40 PM ET
Cerulean Pharma Inc. Promotes Scott Eliasof to Senior Vice President and Chief Scientific Officer
October 26, 2016 11:00 AM ET
Merus N.V. Announces Appointment of L. Andres Sirulnik as Chief Medical Officer
October 26, 2016 11:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Intarcia Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.